RxAnte Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
95
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
11
RxAnte General Information
Description
Provider of predictive analytics and targeted clinical programs intended to improve medication prescribing and adherence. The company's platform specializes in providing high-value pharmacy services and improving medication prescribing, adherence, clinical quality scores, and total cost of care, enabling clients with a good pharmacy experience while working with their prescribers and caregivers to make regimens safer, simpler, and more affordable.
Contact Information
Website
www.rxante.com(Operating Subsidiary)
Corporate Office
- 511 Congress Street
- Suite 803
- Portland, ME 04101
- United States
Corporate Office
- 511 Congress Street
- Suite 803
- Portland, ME 04101
- United States
RxAnte Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
RxAnte Comparisons
Industry
Financing
Details
RxAnte Competitors (9)
One of RxAnte’s 9 competitors is Express Scripts, a Corporate Backed or Acquired company based in Saint Louis, MO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Express Scripts | Corporate Backed or Acquired | Saint Louis, MO | ||||
| SeamlessMD | Venture Capital-Backed | Welland, Canada | ||||
| AMC Health | Private Equity-Backed | New York, NY | ||||
| Optum | Private Equity-Backed | Eden Prairie, MN | ||||
| Epic (Other Healthcare Technology Systems) | Private Equity-Backed | Verona, WI |
RxAnte Patents
RxAnte Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12633389-B1 | Systems and methods for generating user interface data associated with adherence intervention data | Active | 15-Jan-2021 | ||
| US-10318897-B1 | Value of future adherence | Active | 21-Oct-2013 | ||
| US-10706372-B1 | Value of future adherence | Active | 21-Oct-2013 | ||
| US-11586997-B1 | Value of future adherence | Active | 21-Oct-2013 | ||
| US-11887027-B1 | Value of future adherence | Active | 21-Oct-2013 | G06Q10/0631 |
RxAnte Signals
RxAnte Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
RxAnte FAQs
-
When was RxAnte founded?
RxAnte was founded in 2011.
-
Where is RxAnte headquartered?
RxAnte is headquartered in Portland, ME.
-
What is the size of RxAnte?
RxAnte has 95 total employees.
-
What industry is RxAnte in?
RxAnte’s primary industry is Other Healthcare Technology Systems.
-
Is RxAnte a private or public company?
RxAnte is a Private company.
-
What is RxAnte’s current revenue?
The current revenue for RxAnte is .
-
How much funding has RxAnte raised over time?
RxAnte has raised $51.3M.
-
Who are RxAnte’s investors?
Aberdare Ventures, Millennium Health, Oxeon Partners, TA Associates Management, and West Health Investment Fund have invested in RxAnte.
-
Who are RxAnte’s competitors?
Express Scripts, SeamlessMD, AMC Health, Optum, and Epic (Other Healthcare Technology Systems) are some of the 9 competitors of RxAnte.
-
When was RxAnte acquired?
RxAnte was acquired on 22-Dec-2025.
-
Who acquired RxAnte?
RxAnte was acquired by UPMC Enterprises.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process